We are not the Better Business Bureau. We're better!
   About Us
   Our Ratings
   Look up a Company
   File a Complaint
   Complaint Resolution
   Membership - Join Now!
   Member Login
   Contact Us

1,847,292 companies
in our database.

Join our weekly
Consumer Fraud
Alert Newsletter

Our members proudly
display this seal!

News Releases


"AngioGenex, Inc. - Product Pipeline Review - 2014" Published

Global Markets Direct's, 'AngioGenex, Inc. - Product Pipeline Review - 2014', provides an overview of the AngioGenex, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AngioGenex, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Full Report Details at

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


 * The report provides brief overview of AngioGenex, Inc. including business description, key information and facts, and its locations and subsidiaries
 * The report reviews current pipeline of AngioGenex, Inc.'s human therapeutic division and enlists all their major and minor projects
 * The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
 * Special feature on out-licensed and partnered product portfolio
 * The report summarizes all the dormant and discontinued pipeline projects
 * Latest company statement
 * Latest news and deals relating to the AngioGenex, Inc.'s pipeline products

Reasons to Get this Report

 * Evaluate AngioGenex, Inc.'s strategic position with total access to detailed information on its product pipeline
 * Assess the growth potential of AngioGenex, Inc. in its therapy areas of focus
 * Identify new drug targets and therapeutic classes in the AngioGenex, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
 * Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
 * Develop strategic initiatives by understanding the focus areas of AngioGenex, Inc. and exploit collaboration and partnership opportunities
 * Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 * Plan mergers and acquisitions effectively by identifying the most promising pipeline of AngioGenex, Inc.
 * Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 * Explore the dormant and discontinued projects of AngioGenex, Inc. and identify potential opportunities in those areas
 * Avoid Intellectual Property Rights related issues

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
AngioGenex, Inc. Snapshot
AngioGenex, Inc. Overview
Key Information
Key Facts
AngioGenex, Inc. - Research and Development Overview
Key Therapeutic Areas
AngioGenex, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
AngioGenex, Inc. - Pipeline Products Glance
AngioGenex, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
AngioGenex, Inc. - Drug Profiles
Product Description
Mechanism of Action
R&D Progress
Product Description
Mechanism of Action
R&D Progress
Product Description
Mechanism of Action
R&D Progress
AngioGenex, Inc. - Pipeline Products by Molecule Type
AngioGenex, Inc. - Locations And Subsidiaries
Head Office
Secondary Research
Primary Research
Expert Panel Validation
Contact Us

List of Tables
AngioGenex, Inc., Key Information
AngioGenex, Inc., Key Facts
AngioGenex, Inc. - Pipeline by Indication, 2014
AngioGenex, Inc. - Pipeline by Stage of Development, 2014
AngioGenex, Inc. - Monotherapy Products in Pipeline, 2014
AngioGenex, Inc. - Preclinical, 2014
AngioGenex, Inc. - Pipeline by Molecule Type, 2014

List of Figures
AngioGenex, Inc. - Pipeline by Top 10 Indication, 2014
AngioGenex, Inc. - Pipeline by Top 10 Molecule Type, 2014

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available.  Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.


Credit Secrets Bible

Get Paid for
Doing Surveys

The Online Business Bureau -- 21441 Pacific Boulevard -- Suite 200 -- Sterling, VA 20166 -- 202-558-5282
News Releases |  News Articles |  Financial Calculators |  Contact Us |  Privacy Policy | Terms of Use & Legal Notice
Copyright © 2019 Online Business Bureau, L. C.. All Rights Reserved.
We are not affiliated with the Council of Better Business Bureaus, Inc.